Last reviewed · How we verify

Benazolin — Competitive Intelligence Brief

Benazolin (METIZOLINE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: metizoline. Area: Hematology.

phase 2 metizoline Nischarin Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Benazolin (METIZOLINE). Benazolin works by blocking the action of histamine and other substances that cause nasal congestion.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Benazolin TARGET METIZOLINE phase 2 metizoline Nischarin
Zanaflex TIZANIDINE Legacy Pharma Usa marketed Central alpha-2 Adrenergic Agonist Nischarin 1996-01-01
Moxonidin MOXONIDINE marketed moxonidine Nischarin 1991-01-01
Tenex GUANFACINE Promius Pharma marketed Central alpha-2 Adrenergic Agonist Nischarin 1986-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (metizoline class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Benazolin — Competitive Intelligence Brief. https://druglandscape.com/ci/metizoline. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing